vTv Therapeutics (VTVT) Earnings Date & Reports

vTv Therapeutics Inc is a clinical stage biopharmaceutical company focused on the development of orally administered treatments for metabolic and inflammatory diseases to minimize their long-term complications and improve the lives of patients... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

VTVT is expected to report earnings to fall 90.91% to -7 cents per share on February 28

vTv Therapeutics VTVT Stock Earnings Reports

Q4'23

Est.

$-0.07

Q1'25

Beat

by $0.33

Q3'23

Est.

$-0.08

Q2'23

Missed

by $2.73

Q1'23

Beat

by $0.05

The last earnings report on May 15 showed earnings per share of -76 cents, beating the estimate of -110 cents. With 621.00 shares outstanding, the current market capitalization sits at 52.32M.

View a ticker or compare two or three

Compare

Interact to see
Advertisement

A.I.Advisor

published price charts

A.I. Advisor

published General Information

General Information

a clinical-stage pharmaceutical holding company, which focuses on the discovery and development of human therapeutics

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Biotechnology

Address

3980 Premier Drive

Phone

+1 336 841-0300

Employees

Web

https://www.vtvtherapeutics.com